Skip to main content
. 2021 Jun 23;44(10):2269–2276. doi: 10.2337/dc20-1836

Figure 2.

Figure 2

A: Cumulative incidence of type 1 diabetes by the number of positive islet autoantibodies (IA) (one, two, or three) at confirmed seroconversion in the infant-toddler cohort. B: Cumulative incidence of type 1 diabetes among subjects with a single autoantibody at confirmed seroconversion in the infant-toddler cohort. C: Cumulative incidence of type 1 diabetes by HLA risk group among subjects with a stable single autoantibody (S-S) 2 years postseroconversion in the infant-toddler cohort.